Rabiega-Przyłęcka A. Model of Ethical Assessment of Clinical Trials of Medicinal Product after the Entry into Force of Regulation 536/2014 and the Protection of a Clinical Trial Participant – Remarks in the Light of the New Act on Clinical Trials of Medicinal Products for Hum. FOI [Internet]. 2024 Feb. 26 [cited 2024 May 18];:269-80. Available from: https://czasopisma.uni.lodz.pl/Iuridica/article/view/21396